Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Lactams Stories

2014-04-14 12:31:23

Considerable Opportunity Exists for Therapies Offering Reductions in Mortality and Hospitalization Rates, According to Findings from Decision Resources Group BURLINGTON, Mass., April 14, 2014 /PRNewswire/ -- Decision Resources Group finds that Servier's ivabradine (procoralan) is set to become the clinical gold-standard in the treatment of chronic heart failure (CHF). Already available in Europe, where it has enjoyed moderate use in CHF and stable angina patients, ivabradine's sound clinical...

2014-04-12 23:00:44

Arkansas Attorney General Has Asked State Supreme Court to Reconsider Its Decision to Overturn $1.2 Billion Risperdal Lawsuit Verdict Columbus, OH (PRWEB) April 12, 2014 The Risperdal lawsuit lawyers at Wright & Schulte LLC, note that the Arkansas Attorney General has filed a petition with the state’s Supreme Court asking it to reconsider a recent decision which overturned a $1.2 billion Risperdal lawsuit verdict awarded to the state in 2012 over the marketing of the antipsychotic...

2014-04-10 23:01:50

The Firm is representing men and boys in Risperdal lawsuits who allegedly developed gynecomastia, or male breast growth, due to Risperdal. New York, New York (PRWEB) April 10, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) continue to mount in U.S. courts, Bernstein Liebhard LLP notes the publication of a new study which reveals the off-label use of atypical antipsychotic drugs like Risperdal is rising among children in foster care. The research, which was published...

2014-04-08 08:29:08

CARDIFF, Calif., April 8, 2014 /PRNewswire/ -- NI Research has released the April issue of NeuroPerspective, which reviews and assesses migraine therapeutics in development. Migraine is the most common of all neurological disorders. Based on epidemiological studies done in the US and Europe during the 1990s, approximately 12.6% of the population experiences migraine in a given year, with 18% suffering from migraine at some point in their lifetimes. It is estimated that there are 36...

2014-04-06 23:01:17

Study Released as Risperdal Lawsuits Alleging Use of Antipsychotic Drug Caused Gynecomastia (Male Breast Growth) in Men and Boys Continue to Move Forward in Pennsylvania Columbus, OH (PRWEB) April 06, 2014 Wright & Schulte LLC, an experienced law firm representing clients in Risperdal lawsuits, notes that a new study has linked use of the atypical antipsychotic medication to gynecomastia, or male breast growth. The release of the study, which was presented in March at the 2014 Annual...

2014-04-04 23:01:22

The Firm is actively filing Risperdal lawsuits on behalf of men and boys who allegedly suffered gynecomastia, or male breast development, due to their use of Risperdal. New York, New York (PRWEB) April 04, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that the Arkansas Attorney General has announced his intention to seek the reinstatement of a $1.2 billion Risperdal fine overturned by the state’s...

Insomnia Linked To Stroke, More S0 For Diabetics
2014-04-04 10:32:48

Brett Smith for redOrbit.com - Your Universe Online If you’re having trouble sleeping at night, here’s one more thing to keep you awake – insomnia can lead to an increased risk of stroke. According to a new report in Stroke, a journal of the American Heart Association, Taiwan-based research revealed that insomnia raised the chance of hospitalization due to stroke by 54 percent over the course of four years. The study also said the frequency of stroke was eight times greater for...

2014-04-02 23:01:07

The Firm continues to investigate Risperdal lawsuits that allege the atypical antipsychotic drug caused male breast development, or gynecomastia. New York, New York (PRWEB) April 02, 2014 The nationwide law firm of Bernstein Liebhard LLP is actively filing Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) on behalf of individuals who allegedly suffered gynecomastia, or male breast growth, due to their use of the atypical antipsychotic. On March 26, 2014, the Firm filed a claim...

2014-04-02 12:32:38

Both Surveyed Physicians and Payers are Sensitive to the Risk of Next-Day Impairment with Insomnia Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., April 2, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. and European psychiatrists ascribe the highest level of unmet need in insomnia treatment to be for new therapies with a reduced risk of abuse and tolerance. Several currently available insomnia therapies are designated as controlled...

Increased Death Risk From Certain Anti-Anxiety And Sleeping Medicines
2014-04-01 05:31:42

April Flowers for redOrbit.com - Your Universe Online Millions of people around the world find help from drugs that treat anxiety and sleep disorders. A new study from the University of Warwick, however, reveals that anti-anxiety and sleeping medicines have been linked to an increased risk of death. The large study, which tracked 34,727 people for an average of seven and a half years, demonstrates that the risk of death doubles with several anxiolytic (anti-anxiety) drugs or hypnotic...